Acute Efficacy and 6 Months Follow up After Electroconvulsive Therapy - Trial NCT05388461
Access comprehensive clinical trial information for NCT05388461 through Pure Global AI's free database. This phase not specified trial is sponsored by Haukeland University Hospital and is currently Recruiting. The study focuses on Depressive Disorder. Target enrollment is 600 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Haukeland University Hospital
Timeline & Enrollment
N/A
Mar 13, 2013
Dec 01, 2028
Primary Outcome
Change of Montgomery and Åsberg Depression Rating Scale (MADRS) score from pretreatment at posttreatment,Change of Mini Mental State Examination (MMSE-NR) score from pretreatment at posttreatment,Change of Beck depression inventory (BDI) score from pretreatment at posttreatment,Change of Everyday Memory Questionnaire (EMQ) score from pretreatment at posttreatment
Summary
The overall aim of the current project is to assess the acute and long term outcome of ECT
 (both patient and clinician rated) in a non-selected patient cohort from ordinary clinical
 activity, and to seek out factors predicting response and remission, side effects and
 relapse.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05388461
Non-Device Trial